0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-19U16943
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Des γ carboxy Prothrombin DCP Biomarker Market Research Report 2024
BUY CHAPTERS

Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Research Report 2025

Code: QYRE-Auto-19U16943
Report
September 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Des-γ-carboxy Prothrombin (DCP) Biomarker Market

The global market for Des-γ-carboxy Prothrombin (DCP) Biomarker was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Des-gamma-carboxy prothrombin (DCP) is an abnormal form of prothrombin, a clotting factor produced by the liver. This test measures the amount of DCP in the blood to help evaluate whether treatment for one type of liver cancer, hepatocellular carcinoma (HCC), is effective.
North American market for Des-γ-carboxy Prothrombin (DCP) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Des-γ-carboxy Prothrombin (DCP) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Des-γ-carboxy Prothrombin (DCP) Biomarker in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Des-γ-carboxy Prothrombin (DCP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Des-γ-carboxy Prothrombin (DCP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Des-γ-carboxy Prothrombin (DCP) Biomarker.
The Des-γ-carboxy Prothrombin (DCP) Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Des-γ-carboxy Prothrombin (DCP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Des-γ-carboxy Prothrombin (DCP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Des-γ-carboxy Prothrombin (DCP) Biomarker Market Report

Report Metric Details
Report Name Des-γ-carboxy Prothrombin (DCP) Biomarker Market
Segment by Type
  • Hepatocellular Carcinoma
  • Anticoagulant Intoxication
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Des-γ-carboxy Prothrombin (DCP) Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Des-γ-carboxy Prothrombin (DCP) Biomarker Market report?

Ans: The main players in the Des-γ-carboxy Prothrombin (DCP) Biomarker Market are FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific

What are the Application segmentation covered in the Des-γ-carboxy Prothrombin (DCP) Biomarker Market report?

Ans: The Applications covered in the Des-γ-carboxy Prothrombin (DCP) Biomarker Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Des-γ-carboxy Prothrombin (DCP) Biomarker Market report?

Ans: The Types covered in the Des-γ-carboxy Prothrombin (DCP) Biomarker Market report are Hepatocellular Carcinoma, Anticoagulant Intoxication, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hepatocellular Carcinoma
1.2.3 Anticoagulant Intoxication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Perspective (2020-2031)
2.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Growth Trends by Region
2.2.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Dynamics
2.3.1 Des-γ-carboxy Prothrombin (DCP) Biomarker Industry Trends
2.3.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Drivers
2.3.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Challenges
2.3.4 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Revenue
3.1.1 Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Revenue (2020-2025)
3.1.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue
3.4 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Concentration Ratio
3.4.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue in 2024
3.5 Global Key Players of Des-γ-carboxy Prothrombin (DCP) Biomarker Head office and Area Served
3.6 Global Key Players of Des-γ-carboxy Prothrombin (DCP) Biomarker, Product and Application
3.7 Global Key Players of Des-γ-carboxy Prothrombin (DCP) Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Des-γ-carboxy Prothrombin (DCP) Biomarker Breakdown Data by Type
4.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Type (2026-2031)
5 Des-γ-carboxy Prothrombin (DCP) Biomarker Breakdown Data by Application
5.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2020-2031)
6.2 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025)
6.4 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2020-2031)
7.2 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025)
7.4 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2020-2031)
9.2 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025)
9.4 Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM
11.1.1 FUJIFILM Company Details
11.1.2 FUJIFILM Business Overview
11.1.3 FUJIFILM Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.1.4 FUJIFILM Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.1.5 FUJIFILM Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.2.4 Eli Lilly and Company Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.2.5 Eli Lilly and Company Recent Development
11.3 Fujirebio
11.3.1 Fujirebio Company Details
11.3.2 Fujirebio Business Overview
11.3.3 Fujirebio Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.3.4 Fujirebio Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.3.5 Fujirebio Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.4.4 Roche Diagnostics Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.4.5 Roche Diagnostics Recent Development
11.5 Fapon Biotech
11.5.1 Fapon Biotech Company Details
11.5.2 Fapon Biotech Business Overview
11.5.3 Fapon Biotech Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.5.4 Fapon Biotech Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.5.5 Fapon Biotech Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Details
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.6.4 Labcorp Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.6.5 Labcorp Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Des-γ-carboxy Prothrombin (DCP) Biomarker Introduction
11.7.4 Thermo Fisher Scientific Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
11.7.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hepatocellular Carcinoma
 Table 3. Key Players of Anticoagulant Intoxication
 Table 4. Key Players of Others
 Table 5. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region (2020-2025)
 Table 9. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region (2026-2031)
 Table 11. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Trends
 Table 12. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Drivers
 Table 13. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Challenges
 Table 14. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Restraints
 Table 15. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Players (2020-2025)
 Table 17. Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker as of 2024)
 Table 18. Ranking of Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Des-γ-carboxy Prothrombin (DCP) Biomarker, Headquarters and Area Served
 Table 21. Global Key Players of Des-γ-carboxy Prothrombin (DCP) Biomarker, Product and Application
 Table 22. Global Key Players of Des-γ-carboxy Prothrombin (DCP) Biomarker, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Type (2020-2025)
 Table 26. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Type (2026-2031)
 Table 28. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Application (2020-2025)
 Table 30. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue Market Share by Application (2026-2031)
 Table 32. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 47. FUJIFILM Company Details
 Table 48. FUJIFILM Business Overview
 Table 49. FUJIFILM Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 50. FUJIFILM Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 51. FUJIFILM Recent Development
 Table 52. Eli Lilly and Company Company Details
 Table 53. Eli Lilly and Company Business Overview
 Table 54. Eli Lilly and Company Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 55. Eli Lilly and Company Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 56. Eli Lilly and Company Recent Development
 Table 57. Fujirebio Company Details
 Table 58. Fujirebio Business Overview
 Table 59. Fujirebio Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 60. Fujirebio Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 61. Fujirebio Recent Development
 Table 62. Roche Diagnostics Company Details
 Table 63. Roche Diagnostics Business Overview
 Table 64. Roche Diagnostics Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 65. Roche Diagnostics Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 66. Roche Diagnostics Recent Development
 Table 67. Fapon Biotech Company Details
 Table 68. Fapon Biotech Business Overview
 Table 69. Fapon Biotech Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 70. Fapon Biotech Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 71. Fapon Biotech Recent Development
 Table 72. Labcorp Company Details
 Table 73. Labcorp Business Overview
 Table 74. Labcorp Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 75. Labcorp Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 76. Labcorp Recent Development
 Table 77. Thermo Fisher Scientific Company Details
 Table 78. Thermo Fisher Scientific Business Overview
 Table 79. Thermo Fisher Scientific Des-γ-carboxy Prothrombin (DCP) Biomarker Product
 Table 80. Thermo Fisher Scientific Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025) & (US$ Million)
 Table 81. Thermo Fisher Scientific Recent Development
 Table 82. Research Programs/Design for This Report
 Table 83. Key Data Information from Secondary Sources
 Table 84. Key Data Information from Primary Sources
 Table 85. Authors List of This Report


List of Figures
 Figure 1. Des-γ-carboxy Prothrombin (DCP) Biomarker Picture
 Figure 2. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Type: 2024 VS 2031
 Figure 4. Hepatocellular Carcinoma Features
 Figure 5. Anticoagulant Intoxication Features
 Figure 6. Others Features
 Figure 7. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Others Case Studies
 Figure 12. Des-γ-carboxy Prothrombin (DCP) Biomarker Report Years Considered
 Figure 13. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region: 2024 VS 2031
 Figure 16. Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Players in 2024
 Figure 17. Global Top Des-γ-carboxy Prothrombin (DCP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Des-γ-carboxy Prothrombin (DCP) Biomarker as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue in 2024
 Figure 19. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2020-2031)
 Figure 21. United States Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2020-2031)
 Figure 25. Germany Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Region (2020-2031)
 Figure 33. China Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2020-2031)
 Figure 41. Mexico Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Share by Country (2020-2031)
 Figure 45. Turkey Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. FUJIFILM Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 49. Eli Lilly and Company Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 50. Fujirebio Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 51. Roche Diagnostics Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 52. Fapon Biotech Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 53. Labcorp Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Des-γ-carboxy Prothrombin (DCP) Biomarker Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global ENT Surgery Navigation Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11O6178
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Robotics in Laparoscopic Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7R6277
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Bone Allografts Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9I8785
Tue Sep 09 00:00:00 UTC 2025

Add to Cart